The effect of exosomes derived from mesenchymal stem cells in the treatment of induced type 1 diabetes mellitus in rats
- PMID: 32430801
- DOI: 10.1007/s10529-020-02908-y
The effect of exosomes derived from mesenchymal stem cells in the treatment of induced type 1 diabetes mellitus in rats
Erratum in
-
Correction to: The effect of exosomes derived from mesenchymal stem cells in the treatment of induced type 1 diabetes mellitus in rats.Biotechnol Lett. 2020 Dec;42(12):2761-2762. doi: 10.1007/s10529-020-02975-1. Biotechnol Lett. 2020. PMID: 32776304
Abstract
Aim: The aim of the current study was to evaluate the therapeutic and regenerative effects of MSCs derived exosomes in the treatment of type 1 DM and to compare its effects with MSCs themselves. The experiment was done on forty albino rats grouped as follows, group (1): Ten healthy rats, group (2): Ten induced type 1 DM rats, group (3): Ten induced type 1 DM rats received exosomes intraperitoneally, and group (4): Ten induced type 1 DM rats received MSCs intraperitoneally. Serum glucose and plasma insulin levels were assessed weekly. QRT-PCR was done to assess regeneration of pancreatic beta cells by measuring insulin, Pdx1, Smad2, Smad3 and TGFβ genes. Additionally, histopathological and immune-histochemical examinations were done to confirm pancreatic tissue regeneration.
Results: Regarding the assessed genes (insulin, Pdx1, Smad2, Smad3 and Tgfβ) gene expression in MSCs treated group showed significant increase compared to diabetic group (p value < 0.001) and gene expression in exosomes treated group was increased significantly compared to diabetic and MSCs treated groups (p value < 0.001). Histopathological and immune-histochemical examination revealed regeneration of pancreatic islets in both treated groups.
Conclusion: MSCs Derived exosomes showed superior therapeutic and regenerative results than MSCs themselves.
Keywords: Exosomes; Insulin; MSCs; Pdx1; Smad2; Smad3; Tgfβ; Type 1 DM.
Similar articles
-
The Potential of Mesenchymal Stem Cell-Derived Exosomes to Treat Diabetes Mellitus.Biomimetics (Basel). 2025 Jan 14;10(1):49. doi: 10.3390/biomimetics10010049. Biomimetics (Basel). 2025. PMID: 39851765 Free PMC article. Review.
-
Potential of stem cell-derived exosomes to regenerate β islets through Pdx-1 dependent mechanism in a rat model of type 1 diabetes.J Cell Physiol. 2019 Nov;234(11):20310-20321. doi: 10.1002/jcp.28631. Epub 2019 Apr 17. J Cell Physiol. 2019. PMID: 30997693
-
Mesenchymal stem cell-derived exosomes improve diabetes mellitus-induced myocardial injury and fibrosis via inhibition of TGF-β1/Smad2 signaling pathway.Cell Mol Biol (Noisy-le-grand). 2019 Sep 30;65(7):123-126. Cell Mol Biol (Noisy-le-grand). 2019. PMID: 31880529
-
Role of adipose tissue derived stem cells differentiated into insulin producing cells in the treatment of type I diabetes mellitus.Gene. 2018 May 15;654:87-94. doi: 10.1016/j.gene.2018.02.008. Epub 2018 Feb 13. Gene. 2018. PMID: 29452233
-
Ageing and mesenchymal stem cells derived exosomes: Molecular insight and challenges.Cell Biochem Funct. 2021 Jan;39(1):60-66. doi: 10.1002/cbf.3602. Epub 2020 Nov 8. Cell Biochem Funct. 2021. PMID: 33164248 Review.
Cited by
-
Extracellular vesicles as tools and targets in therapy for diseases.Signal Transduct Target Ther. 2024 Feb 5;9(1):27. doi: 10.1038/s41392-024-01735-1. Signal Transduct Target Ther. 2024. PMID: 38311623 Free PMC article. Review.
-
Transplantation of engineered exosomes derived from bone marrow mesenchymal stromal cells ameliorate diabetic peripheral neuropathy under electrical stimulation.Bioact Mater. 2021 Jan 22;6(8):2231-2249. doi: 10.1016/j.bioactmat.2021.01.008. eCollection 2021 Aug. Bioact Mater. 2021. PMID: 33553812 Free PMC article.
-
The Role of Mesenchymal Stromal Cells-Derived Small Extracellular Vesicles in Diabetes and Its Chronic Complications.Front Endocrinol (Lausanne). 2021 Dec 20;12:780974. doi: 10.3389/fendo.2021.780974. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34987478 Free PMC article. Review.
-
The Potential of Mesenchymal Stem Cell-Derived Exosomes to Treat Diabetes Mellitus.Biomimetics (Basel). 2025 Jan 14;10(1):49. doi: 10.3390/biomimetics10010049. Biomimetics (Basel). 2025. PMID: 39851765 Free PMC article. Review.
-
Exosomes as Promising Nanostructures in Diabetes Mellitus: From Insulin Sensitivity to Ameliorating Diabetic Complications.Int J Nanomedicine. 2022 Mar 19;17:1229-1253. doi: 10.2147/IJN.S350250. eCollection 2022. Int J Nanomedicine. 2022. PMID: 35340823 Free PMC article. Review.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical